Why pharmacovigilance is moving from workflow automation to AI-assisted decision intelligence

drugdiscoverytrends.com berichtet ueber Why pharmacovigilance is moving from workflow automation to AI-assisted decision intelligence. Today’s pharmacovigilance (PV) teams face mounting pressure to analyze increasingly larger volumes of safety data while meeting progressively complex global reporting expectations. According to Deloitte’s 2026 Life Sciences Outlook , 48% of life sciences executives say the rapid adoption of digital technologies and data analytics will substantially impact their organizations. Another area of growing interest is agentic AI, with 30% noting its importance.

Das Bild wird durch weitere Entwicklungen schaerfer: HousingWire: Buying AI tools in real estate, measure the full task not the demo: Before buying real estate AI software, time end to end workflows, define the result, and check true cost, integration and support quality, The AI Journal: The Next Creative: What followed afterward among creators was a buzz about “prompting” and “prompt engineering” und ai tools - BingNews: AI Tools Aren’t Going To Replace Anyone, Says GTA 6: Strauss Zelnick weighs in on the future of AI in game development during the latest investor call for GTA 6's parent company.

Damit wird das Thema AI, Tools und Prompt konkreter: Aus einzelnen Nachrichten entsteht ein sichtbarer Trend rund um KI-Agenten und Tools. Entscheidend ist jetzt, ob aus den angekuendigten Projekten, Werkzeugen oder Sicherheitsmassnahmen ein praktischer Nutzen entsteht.